Similar articles

• Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".

  Seeman P. Seeman P. Neuropsychopharmacology. 1992 Aug;7(1):55-7; discussion 73-5. Neuropsychopharmacology. 1992. PMID: 1388022 No abstract available.
• Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.

  Seeman P, Niznik HB, Guan HC. Seeman P, et al. Arch Gen Psychiatry. 1990 Dec;47(12):1170-2. doi: 10.1001/archpsyc.1990.01810240090014. Arch Gen Psychiatry. 1990. PMID: 2244801 No abstract available.
• The current status of PET scanning with respect to schizophrenia.

  Sedvall G. Sedvall G. Neuropsychopharmacology. 1992 Aug;7(1):41-54. Neuropsychopharmacology. 1992. PMID: 1388021 Review.
• Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.

  Wang GJ, Volkow ND, Fowler JS, Wolf AP, MacGregor RR, Shea CE, Schlyer DJ, Hitzemann RJ. Wang GJ, et al. Synapse. 1993 Nov;15(3):246-9. doi: 10.1002/syn.890150311. Synapse. 1993. PMID: 8278901 No abstract available.
• Raclopride, a new selective ligand for the dopamine-D2 receptors.

  Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Hall H, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):559-68. doi: 10.1016/0278-5846(88)90001-2. Prog Neuropsychopharmacol Biol Psychiatry. 1988. PMID: 2975809 Review.